The current state of in-vivo pre-clinical animal models for heart valve evaluation

被引:0
|
作者
Gallegos, RP
Nockel, PJ
Rivard, AL
Bianco, RW
机构
[1] Univ Minnesota, Dept Surg, Expt Surg Serv, Minneapolis, MN 55455 USA
[2] Lillehei Heart Inst, Minneapolis, MN USA
来源
JOURNAL OF HEART VALVE DISEASE | 2005年 / 14卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For over 30 years, animal models have remained a central critical component in the pre-clinical safety evaluation of prosthetic heart valves developed for use in humans. Though many advances have been made in valve design, no ideal replacement prosthesis has yet been developed. As a result, valve manufacturers continue to address issues relating to thrombogenicity, structural integrity, fluid dynamics and calcification in their designs. Many animal models have been developed to examine these issues, including dog, pig, calf and sheep, yet no standard model has been accepted. Recently, the International Standard Organization has provided guidelines in document 5840 to address cardiovascular implants. The aim of this report is to provide a summary of the current state of pre-clinical valve evaluation in animals. Changes in ISO 5840 will be addressed that have occurred between 1998 and the present date, and the role of current available animal models. The aim also is to provide rational guidance in the selection of appropriate animal models to match the purpose of valve implantation studies.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 50 条
  • [1] Pre-clinical In Vitro and In Vivo Models for Heart Valve Therapies
    Taramasso, Maurizio
    Emmert, Maximilian Y.
    Reser, Diana
    Guidotti, Andrea
    Cesarovic, Nikola
    Campagnol, Marino
    Addis, Alessandro
    Nietlispach, Fabian
    Hoerstrup, Simon P.
    Maisano, Francesco
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2015, 8 (05) : 319 - 327
  • [2] Pre-clinical In Vitro and In Vivo Models for Heart Valve Therapies
    Maurizio Taramasso
    Maximilian Y. Emmert
    Diana Reser
    Andrea Guidotti
    Nikola Cesarovic
    Marino Campagnol
    Alessandro Addis
    Fabian Nietlispach
    Simon P. Hoerstrup
    Francesco Maisano
    Journal of Cardiovascular Translational Research, 2015, 8 : 319 - 327
  • [3] PRE-CLINICAL EVALUATION OF LENTINAN IN ANIMAL-MODELS
    CHIHARA, G
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1983, 166 : 189 - 197
  • [4] Pre-clinical animal models of osteoarthritis
    Chen, Qian
    Wei, Lei
    Yang, Xu
    BONE, 2010, 47 : S350 - S351
  • [5] Current state of in vivo preclinical heart valve evaluation
    Salerno, CT
    Droel, J
    Bianco, RW
    JOURNAL OF HEART VALVE DISEASE, 1998, 7 (02): : 158 - 162
  • [6] Advanced Periodontal Pre-Clinical Animal Models
    Lakshmi, P.
    Sowmya, S.
    Trends in Biomaterials and Artificial Organs, 2022, 36 (02): : 111 - 120
  • [7] In vivo infection models in the pre-clinical pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents
    Andes, David R.
    Lepak, Alex J.
    CURRENT OPINION IN PHARMACOLOGY, 2017, 36 : 94 - 99
  • [8] Evaluation of the clinical relevance and limitations of current pre-clinical models of peripheral artery disease
    Krishna, Smriti Murali
    Omer, Safraz Mohamed
    Golledge, Jonathan
    CLINICAL SCIENCE, 2016, 130 (03) : 127 - 150
  • [9] Animal models of autoimmunity: a relentless pursuit of accurate pre-clinical models
    Morel, Laurence
    AUTOIMMUNITY, 2025, 58 (01)
  • [10] Targeted therapy evaluation in novel pre-clinical in vitro and in vivo models of Richter transformation
    Fiskus, Warren C.
    Maiti, Abhishek
    Saenz, Dyana T.
    Mill, Christopher P.
    Khoury, Joseph D.
    Bhalla, Kapil N.
    CANCER RESEARCH, 2019, 79 (13)